proliferative status of human hematopoietic progenitor cells. Human Gene Therapy l(3):257-268, 1990. 
12.0zkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C. Hepatic veno-occlusive disease post-bone marrow 
transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone 
Marrow Transplantation 7:467-474, 1991. 
13. Weinthal J, Nolta JA, Yu X-J, Lilley J, Uribe L, Kohn D. Expression of human glucocerebrosidase following retroviral vector- 
mediated transduction of murine hematopoietic stem cells. Bone Marrow Transplantation 8:403-412, 1991. 
14. Bedgood RM, Bahner I, Kohn DB, and Stallcup MR. Hormonemediated envelope processing in the MMTV infected W7MG1 
cell line is a consequence of differential expression of processable and non-processable envelope gene. Molecular Endocrinology 
6:459-467, 1992. 
15. Nolta JA, Yu XJ, Bahner I, and Kohn DB. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured 
Gaucher bone marrow. Journal of Clinical Investigation 90:342-348, 1992. 
16. Nolta JA, Crooks GM, Overell RW, Williams DE, and Kohn DB. Retroviral vector-mediated gene transfer into primitive 
human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines. Experimental 
Hematology 20:1065-1071, 1992. 
17. Miller AR, Skotzko MJ, Rhoades K, Belldegrun AS, Tso C-L, Kaboo R, McBride WH, Jacobs E, Kohn D, Moen R, Economou 
JS. Simultaneous use of two retroviral vectors in human gene marking trials: feasibility and potential applications. 
Human Gene Therapy 3:619-624, 1992. 
18. Bahner I, Zhou C, Yu XJ, Hao QL, Kohn DB. Comparison of 7>a/i5-dominant inhibitory mutant human immunodeficiency 
virus Type 1 genes expressed by retroviral vectors in human T lymphocytes. (J of Virology, In Press). 
19. Weinberg K, Hershfield MS, Bastian J, Kohn D, Sender L, Parkman R, Lenarsky C. T lymphocyte ontogeny in adenosine 
deaminase deficient servere combined immune deficiency following treatment with polyethylene glycol modified adenosine 
deaminase. (J Clin Inves, Accepted). 
20. Nolta JA, Hanley M, Kohn DB. Co-transplantation of human marrow stromal cells producing IL-3 with CD34+ progenitor cells 
supports persistent human myelopoiesis in immunodeficient mice. In Preparation. 
21. Challita PM, El-Khoueiry AB, Kohn DB. Silencing of retroviral vectors after transduction of murine hematopoietic stem cells is 
associated with methylation. In Preparation. 
22. Crooks GM, Nolta JA, Hanley M, Lyons RM, Moen RC, Kohn DB. Growth factors increase binding of amphotropic retrovirus 
to CD34+ human bone marrow progenitors. In Preparation. 
23. Challita PM, Cook C, Zhou C, Weinberg KI, Sender L, Kohn DB. Inhibition of methylation of a retroviral vector in embryonic 
stem (ES) cells by inclusion of a CpG island in the long terminal repeat (LTR). In Preparation. 
24. Zhou C, Bahner I, Larson G, Rossi J, Kohn DB. Anti-HIV-1 hammerhead ribozymes transduced by retroviral vectors inhibit 
HIV-1 replication in human T lymphocytes. In Preparation. 
Selected Abstracts. Symposia, Invited Articles 
1. Kohn DB, Moen RC, Kantoff PW, Anderson WF, and Blaese RM. Transfer and expression of the human adenosine deaminase 
(ADA) gene in ADA-deficient lymphocytes using retroviral vectors. Blood 68 (Suppl 1) :306a, 1986. 
2. Blaese R, Kohn DB, Moen RC. The treatment of adenosine deaminase deficiency. Immunol Today 8:296-97, 1987. 
3. Kohn DB, Nolta JA, Stephens D, Jacobs K, Rossi JJ, Zaia JA. Retroviral vectors producing HIV antisense RNA block HIV 
infection. Blood 72 (Suppl l):355a, 1988. 
4. Nolta J, Sender LS, Barranger JA, Kohn DB. Retroviral-mediated transfer of the human glucocerebrosidase gene. Blood 72 
(Suppl l):398a, 1988. 
5. Kohn DB, Anderson WF, Blaese RM. Gene therapy for genetic diseases. Cancer Investigation 7:179-92, 1989. 
6. Nolta JA, Kohn DB. Hematopoietic growth factors increase retroviral vector-mediated gene transfer into human progenitor 
cells. Blood 74 (Suppl 1):233A, 1989. 
7. Kohn D, Nolta J, Weinthal J, and Bahner I. Towards gene therapy for Gaucher disease. Human Gene Therapy 
2:101-105, 1991. 
8. Lenarsky C, Weinberg K, Kohn DB, Sender L, Brooks J, Annett G, Nolta J, and Parkman R. Bone marrow transplantation 
(BMT) for children with acute lymphoblastic leukemia (ALL) with busulfan (BU) and Cyclophosphamide (CY). Blood 78:239a, 
1991. 
Book Chapter 
Lenarsky C, Kohn DB, Weinberg KI, and Parkman R. Bone marrow transplantation for genetic diseases. In Hema- 
tology/On colopv Clinics of North America . Forman SJ (Ed), Philadelphia: W.B. Saunders, 589-602, 1990. 
Parkman R, Kohn DB. Gene therapy for inborn errors of metabolism. Genetics, Ethics and Human Values - Human Genome 
M apping. Generic Screening and Gene Therapy . Proceedings of the XXIVth CIOMS Round Table Conference Edited by Z. 
Bankowski and A.M. Capron held in Tokyo and Inuyama, Japan, July 1990. 
Recombinant DNA Research, Volume 17 
[851] 
